America’s biopharmaceutical companies are proud to be at the forefront of the battle against cancer, working tirelessly to develop innovative approaches for more effective treatments for patients. Over the weekend, we saw this innovation at work when former President Jimmy Carter announced that he is cancer free following treatment for metastatic melanoma since August. This follows on the heels of Maryland Governor Larry Hogan’s announcement last month that he is also “100 percent cancer-free.”
President Carter and Governor Hogan have spoken openly about their treatment plans, which included surgery, radiation, chemotherapy and new cutting-edge immunotherapy treatments. Unlike many cancer medicines that kill cancer cells, immunotherapy treatments harness the body’s own immune system to fight the cancer and are among the most promising new approaches to treating this complicated disease.
Today, researchers are hard at work with 836 medicines and vaccines in development for cancer, 80 percent of which have the potential to be first-in-class treatments. Our hope is that these treatments will turn many more cancer patients like President Carter and Governor Hogan into survivors.
To learn more about advances in cancer care, please visit http://www.fromhopetocures.org/fighting-cancer.
Tina Stow Tina Stow previously served as Vice President of Communications at PhRMA. Prior to joining PhRMA in 2014, she spent more than a dozen years in corporate and agency communications and public affairs roles. A D.C. transplant via North Carolina and Georgia, Tina likes to travel, make the rounds to D.C.’s new restaurants, dote on her rescue labradoodle (Chloe), and complain about winter.